Drawing primarily on Australian material but with reference to US and to a lesser extent UK materials, this book provides an overview of the interaction between social and institutional forces shaping medical autonomy. The various forces which will be examined include the consumer and women's movements, Bioethics, the common law and government. Although each of these forces has developed independently, nevertheless there is a common interest in underlying concepts of patients' rights and autonomy. The effects of each of these forces is examined in the context of the clinical relationship with particular reference to information disclosure and the rights of patients to refuse and demand treatment. The book will be also concerned with the effect of these forces in professional self-regulation.
Reihe
Sprache
Verlagsort
Verlagsgruppe
Zielgruppe
Für höhere Schule und Studium
Für Beruf und Forschung
Illustrationen
Maße
Höhe: 162 mm
Breite: 241 mm
Gewicht
ISBN-13
978-1-85521-077-6 (9781855210776)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
Part 1 The forces of change: the consumer movement; the women's movement; bioethics; overview. Part 2 Consent to medical treatment: Australian common law regulation of information dislosure; American Common law regulation of information disclosure; theories and views on information disclosure; recent Australian developments; overview. Part 3 Refusal of medical treatment: the United States president's commission for the study of ethical problems in medicine and biomedical and behavioural research 1980-3; American judicial decisions concerning treatment refusal; theories and views on refusal on treatment issues; recent American legislative developments; Australian developments - Victorian law; overview. Part 4 Regulation of human subject research: human subject research policy and regulation in the United States; Australian regulation of human subject research; theories and views on research ethics committees; overview. Part 5 Recent developments in human subject research regulation in Australia and the United States: access to unapproved cancer treatments; access to unapproved drugs for HIV/AIDS treatment; Australian controls governing new drug approval; theories and ideas concerning developments in regulatory policies and community-based research initiatives; overview. Part 6 Patients as decision-makers - a postscript.
